Related Experiment Video
Updated: Aug 23, 2025
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
Adlina Roslan1, Nurshahira Sulaiman2, Khairul Asri Mohd Ghani3
1Laboratory of UPM-MAKNA Cancer Research (CANRES), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Abstract:
Bladder cancer (BC) recurrence is one of the primary clinical problems encountered by patients following chemotherapy. However, the mechanisms underlying their resistance to chemotherapy remain unclear. Alteration in the pattern of membrane proteins (MPs) is thought to be associated with this recurrence outcome, often leading to cell dysfunction. Since MPs are found throughout the cell membrane, they have become the focus of attention for cancer diagnosis and treatment. Identifying specific and sensitive biomarkers for BC, therefore, requires a major collaborative effort. This review describes studies on membrane proteins as potential biomarkers to facilitate personalised medicine. It aims to introduce and discuss the types and significant functions of membrane proteins as potential biomarkers for future medicine. Other types of biomarkers such as DNA-, RNA- or metabolite-based biomarkers are not included in this review, but the focus is mainly on cell membrane surface protein-based biomarkers.
Insights
Bladder cancer recurrence after chemotherapy is a major issue. This review focuses on cell membrane proteins as potential biomarkers for personalized medicine to improve treatment outcomes.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Bladder cancer (BC) recurrence post-chemotherapy presents a significant clinical challenge.
- The mechanisms driving chemotherapy resistance in bladder cancer remain poorly understood.
- Alterations in membrane protein (MP) expression patterns are implicated in BC recurrence and cell dysfunction.
Purpose of the Study:
- To review existing studies on membrane proteins as potential biomarkers for bladder cancer.
- To discuss the types and functions of MPs relevant to personalized medicine in BC.
- To highlight the importance of cell membrane surface protein biomarkers for future therapeutic strategies.
Main Methods:
- Literature review of studies investigating membrane proteins in bladder cancer.
- Analysis of research focusing on MPs as diagnostic and therapeutic targets.
- Synthesis of information on the role of MPs in chemotherapy resistance and recurrence.
Main Results:
- Membrane proteins are increasingly recognized for their role in bladder cancer progression and treatment resistance.
- Specific MPs show potential as sensitive and specific biomarkers for early detection and prognosis.
- Understanding MP alterations can guide the development of targeted therapies and personalized treatment plans.
Conclusions:
- Membrane proteins represent promising biomarkers for bladder cancer, facilitating personalized medicine approaches.
- Further research into MP functions and expression patterns is crucial for clinical translation.
- Focusing on cell membrane surface proteins offers a targeted strategy for improving bladder cancer management.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:38Mitogens and the Cell Cycle
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...